Project Grant R01DK139062
- This Project Grant award of $249,000.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) to New York University aims to improve understanding of how hunger and satiety neurons regulate the activity of downstream neurons in the hypothalamus. Specifically, the research will use novel molecular and optical tools to measure and manipulate cyclic AMP (cAMP) signaling in paraventricular hypothalamic neurons that express melanocortin-4 receptors (PVHMC4R), which...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $1,074,199 to the Albert Einstein College of Medicine to conduct research on the top-down regulation of feeding-related behavior. The research aims to define the connectivity between hypothalamus melanocortin peptide expressing neurons and melanocortin 4 receptor (MC4R)-expressing neurons...
- This Project Grant award of $170,640 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to investigate the role of the FGFR1 signaling pathway in the intersection between reproduction and metabolism. The primary objectives of this 5-year research project are to: (1) conduct a recall-by-genotype study and in-depth neuroendocrine and metabolic phenotyping in...
- This Project Grant award of $151,040, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research examining sex-specific effects and the role of ovarian hormones in striatal-mediated food-seeking behaviors. The project, conducted by the Regents of the University of Michigan, aims to provide insight into how excitatory neurotransmission is regulated in...
- This $1,280,753 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program) supports research on the role of hypothalamic SH2B1 neurocircuits and SH2B1 signal transduction pathways in obesity and metabolic disease. The research, conducted by the Regents of the University of Michigan, aims to identify SH2B1-expressing neurons in the paraventricular hypothalamus (PVH) that control...
- The federal Project Grant award R21HD115119, totaling $531,174, was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant aims to develop and test novel dual agonist therapies targeting the melanocortin and gut-peptide receptors for the treatment of childhood obesity. The research plan includes two specific aims: 1) fully characterizing and optimizing a GLP-1R/MC4R dual...
- This $824,655 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research aimed at understanding the role of sex-biased transcription factors in conferring protection against metabolic dysfunction-associated steatotic liver disease (MASLD) in females. The research will use adult-onset, hepatocyte-specific knockdown technology to elucidate...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $196,460.00 to Oregon Health & Science University (OHSU) to conduct research on the mechanisms underlying the disruption of ovulation and fertility caused by misalignment of light and food cues. The research aims to 1) map the neural circuits connecting the circadian system and...
- This $361,250 Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will support a Phase 2 randomized, placebo-controlled, crossover trial in 20 patients aged 6 years or older with melanocortin obesity syndrome (MCOS) caused by loss-of-function variants in the MC4R gene. The goal is to evaluate the effectiveness of the drug atomoxetine, an...
- This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $176,500.00 to the University of Washington to investigate the links between hypothalamic microglia activation and perineuronal net (PNN) loss in the arcuate nucleus, and how these changes contribute to the pathogenesis of diet-induced obesity and glucose regulation. The...
UNCOVERING THE ROLE OF HYPOTHALAMIC CILIARY CAMP SIGNALING IN SEX-SPECIFIC CONTROL OF METABOLIC HOMEOSTASIS - PROJECT SUMMARY / ABSTRACT DESPITE SIMILAR OBESITY RATES IN BOTH SEXES, THE UNDERLYING BIOLOGY OF EXCESSIVE WEIGHT GAIN IN WOMEN AND MEN IS BELIEVED TO DIFFER SIGNIFICANTLY. NEURONS IN THE VENTROMEDIAL NUCLEUS OF THE HYPOTHALAMUS (VMH) EXHIBIT SEXUALLY DIMORPHIC CHARACTERISTICS AND PLAY A CRUCIAL ROLE IN ENERGY BALANCE. HOWEVER, THE SIGNALING PATHWAYS WITHIN VMH NEURONS THAT CONTRIBUTE TO SEX-SPECIFIC CONTROL OF ENERGY BALANCE REMAIN LARGELY UNKNOWN. RECENTLY, THE PRIMARY CILIUM, A SOLITARY ANTENNA-LIKE SENSORY ORGANELLE FOUND IN MOST MAMMALIAN CELLS, INCLUDING NEURONS, HAS EMERGED AS A CRITICAL REGULATOR OF METABOLIC HOMEOSTASIS. HUMAN GENETIC STUDIES HAVE IDENTIFIED THE CILIA-SPECIFIC ADENYLATE CYCLASE 3 (ADCY3) AS A SIGNIFICANT OBESITY-RISK GENE AND ANIMAL STUDIES HAVE FURTHER SHOWN THAT GLOBAL ADCY3 KNOCKOUT MICE DEVELOP SEVERE OBESITY, PARTICULARLY IN FEMALES. HOWEVER, THE MECHANISM UNDERLYING ADCY3'S CONTRIBUTION TO FEMALE-BIASED WEIGHT GAIN REMAINS UNKNOWN. OUR RECENT FINDINGS INDICATE THAT SELECTIVE DELETION OF ADCY3 IN VMH NEURONS LEADS TO FEMALE-SPECIFIC OBESITY WITHOUT A SIGNIFICANT INCREASE IN FOOD INTAKE. ADCY3 IS ENRICHED IN ESTROGEN RECEPTOR ALPHA (ERA)- AND MELANOCORTIN 4 RECEPTOR (MC4R)-EXPRESSING NEURONS IN THE VENTROLATERAL SUBDIVISION OF VMH (VMHVL), WHICH ARE KNOWN TO AFFECT ENERGY EXPENDITURE (EE) IN FEMALE MICE. ADDITIONALLY, WE FOUND THAT ERA BINDS TO A PUTATIVE PROMOTER REGION OF THE ADCY3 GENE. BASED ON THESE COMPELLING PRELIMINARY OBSERVATIONS AND PREVIOUS LITERATURE SUGGESTING THAT MC4R, A GAS-COUPLED RECEPTOR ENRICHED IN PRIMARY CILIA, IS A DIRECT TRANSCRIPTIONAL TARGET OF ERA WITHIN VMHVL NEURONS AND INCREASES EE SPECIFICALLY IN FEMALE MICE, WE PROPOSE A NOVEL HYPOTHESIS THAT ADCY3 FUNCTIONS DOWNSTREAM OF ERA-DRIVEN MC4R SIGNALING AT THE PRIMARY CILIUM OF VMHVL NEURONS TO INCREASE EE IN FEMALES BY MODULATING THE EXCITABILITY AND/OR NEUROTRANSMISSION OF THESE NEURONS. THIS HYPOTHESIS WILL BE TESTED BY PURSUING FOLLOWING THREE AIMS: AIM-1) DETERMINE IF VMHVL ADCY3 IS NECESSARY FOR METABOLIC HOMEOSTASIS BY ACTING DOWNSTREAM OF ESTROGEN-ERA AND MC4R SIGNALING, AIM-2) DETERMINE IF INCREASING ADCY3 ACTIVITY IN VMHVL ERA+ NEURONS IS SUFFICIENT TO PROTECT AGAINST OBESITY, AND AIM-3) DETERMINE IF LOSS OF ADCY3 REDUCE THE EXCITABILITY AND/OR THE NEUROTRANSMITTER RELEASE OF VMHVL ERA+ NEURONS. THE PROPOSED RESEARCH AIMS TO SIGNIFICANTLY ADVANCE OUR UNDERSTANDING OF HYPOTHALAMIC SIGNALING PATHWAYS INVOLVED IN SEX-SPECIFIC REGULATION OF ENERGY HOMEOSTASIS. ADDITIONALLY, IT WILL PROVIDE NEW INSIGHTS INTO THE LARGELY UNKNOWN MECHANISMS BY WHICH CILIARY CAMP SIGNALING AFFECTS THE PHYSIOLOGY OF KEY HYPOTHALAMIC NEURONS THAT ARE CRUCIAL FOR METABOLIC HOMEOSTASIS. SUCH KNOWLEDGE MAY ULTIMATELY LEAD TO THE DEVELOPMENT OF A NOVEL STRATEGY TO EFFECTIVELY PREVENT OR TREAT OBESITY IN FEMALES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $576.8k | 6/24/25 | ||
| Not listed | $576.8k | 7/3/24 |